0001123292-19-000436.txt : 20190305
0001123292-19-000436.hdr.sgml : 20190305
20190305180754
ACCESSION NUMBER: 0001123292-19-000436
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190301
FILED AS OF DATE: 20190305
DATE AS OF CHANGE: 20190305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McElhaugh Michael J.
CENTRAL INDEX KEY: 0001635326
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34949
FILM NUMBER: 19660148
MAIL ADDRESS:
STREET 1: C/O ONCORE BIOPHARMA, INC.
STREET 2: 3805 OLD EASTON ROAD
CITY: DOYLESTOWN
STATE: PA
ZIP: 18902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arbutus Biopharma Corp
CENTRAL INDEX KEY: 0001447028
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980597776
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
BUSINESS PHONE: 604-419-3200
MAIL ADDRESS:
STREET 1: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
FORMER COMPANY:
FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS Corp
DATE OF NAME CHANGE: 20110607
FORMER COMPANY:
FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS CORP
DATE OF NAME CHANGE: 20081003
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2019-03-01
0001447028
Arbutus Biopharma Corp
ABUS
0001635326
McElhaugh Michael J.
C/O ARBUTUS BIOPHARMA CORPORATION
100-8900 GLENLYON PARKWAY
BURNABY
A1
V5J 5J8
BRITISH COLUMBIA, CANADA
0
1
0
0
Chief Business Officer
Employee Stock Option (Right to Buy)
4.57
2019-03-01
4
A
0
104500
0
A
2029-03-01
Common Shares
104500
104500
D
The option will vest and become exercisable in three equal annual installments beginning March 1, 2020.
/s/ David C. Hastings, as attorney-in-fact for Michael J. McElhaugh
2019-03-05